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The Karnofsky Performance Status (KPS) scale has been widely validated for
clinical practice for over 60 years.
AIM
To examine the extent to which poor pre-transplant functional status, assessed
using the KPS scale, is associated with increased risk of mortality and/or graft
failure at 1-year post-transplantation.
METHODS
This study included 38278 United States adults who underwent first, non-urgent,
liver-only transplantation from 2005 to 2014 (Scientific Registry of Transplant
Recipients). Functional impairment/disability was categorized as severe,
moderate, or none/normal. Analyses were conducted using multivariable-
adjusted Cox survival regression models.
RESULTS
The median age was 56 years, 31% were women, median pre-transplant Model
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for End-Stage for Liver Disease score was 18. Functional impairment was present
in 70%; one-quarter of the sample was severely disabled. After controlling for key
recipient and donor factors, moderately and severely disabled patients had a 1-
year mortality rate of 1.32 [confidence interval (CI): 1.21-1.44] and 1.73 (95%CI:
1.56-1.91) compared to patients with no impairment, respectively. Subjects with
moderate and severe disability also had a multivariable-adjusted 1-year graft
failure rate of 1.13 (CI: 1.02-1.24) and 1.16 (CI: 1.02-1.31), respectively.
CONCLUSION
Pre-transplant functional status is a useful prognostic indicator for 1-year post-
transplant patient and graft survival.
Key words: Patient survival; Transplantation; Liver disease; Clinical decision-making;
Graft survival; Risk assessment/risk stratification
©The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.
Core tip: Poor functional status, as defined by The Karnofsky Performance Status scale,
is a strong predictor of worse 1-year post-transplant outcomes (patient and graft survival)
in a national United States liver transplant population.
Citation: Dolgin NH, Movahedi B, Anderson FA, Brüggenwirth IM, Martins PN,
Bozorgzadeh A. Impact of recipient functional status on 1-year liver transplant outcomes.




Due to increasing organ shortages in the United States, patients on the liver transplant
waiting  list  are  older  and sicker  than  ever  before,  while  wait  time continues  to
climb[1-3]. Among the 15000 patients with End-Stage Liver Disease on the transplant
waiting list in 2013, 20% were over 65 years old, 20% had been waiting for at least 5
years already, 20% died while awaiting transplant; fewer than 6000 patients received
an organ[2]. In 2002, in response to increasing shortages and waitlist mortality, the liver
allocation system was reorganized to  prioritize  patients  according to  urgency[4].
“Urgency” was defined according to risk of 3-month mortality, calculated using 3
objective laboratory values (creatinine, bilirubin, international normalized ratio) to
create individualized Model for End-Stage for Liver Disease (MELD) scores used to
rank patients. Although this system successfully lowered population-level waitlist
mortality rates, it is an insufficient summary measure for describing global health
status[5,6],  and  has  recently  been  shown  to  underestimate  mortality  risk  among
subgroups of “frail” patients[6-8].
Frailty is increasingly recognized as an important predictor of outcomes after major
surgical procedures including liver transplantation[9-11]. Frailty syndrome is defined by
a  cluster  of  signs  and  symptoms  that  are  hallmark  sequelae  of  liver  disease,
malnutrition, sarcopenia, functional impairment/disability, which ultimately lead to
increased vulnerability to stressors due to depleted physiologic reserve[12]. However,
there is no gold standard measure of frailty[13].
Liver and lung transplant centers in the United States are mandated to submit
Karnofsky Performance Status (KPS) functional status data on all patients, with other
clinical data, to the Organ Procurement and Transplantation Network (OPTN) each
quarter. This frailty measure has been widely used in clinical practice and research for
over 60 years and has been extensively validated across a wide range of  disease
groups  including  transplant,  liver  disease,  and  End-Stage  Renal  Disease
populations[14-27]. However, though several studies have used KPS as a predictor of
liver transplant outcomes, the majority of studies were limited in generalizability as
they were either single-center studies[28,29], conducted outside of the United States[11,30],
limited to the early post-transplant period[11,30,31],  and/or took place before MELD
implementation,  at  which  point  the  transplant  recipient  population  shifted
dramatically[28,32]. In 2013, the Liver and Intestinal Transplant Committee of OPTN
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publicly asked for researchers to fill this gap in the literature regarding the utility of
the KPS scale in a national liver transplant population[18].
To our knowledge, this will be the first study to evaluate a standardized, validated
measure of functional status as a predictor of 1-year post-transplant outcomes in a
national  United  States  liver  transplant  population.  Using  data  from  the  only
comprehensive  nationwide  transplant  database,  the  United  Network  for  Organ
Sharing (UNOS) Scientific Registry of Transplant Recipients (SRTR), we assessed the
clinical utility of the KPS scale for the prediction of 1-year post-liver transplant patient
and graft survival.
MATERIALS AND METHODS
Study design and sample
This retrospective cohort study used data from the SRTR. The SRTR is contracted to
UNOS by the United States Department of Health and Human Services to manage
data collected via government-mandated reporting by all United States transplant
centers. This study was deemed exempt by the University of Massachusetts Medical
School Institutional Review Board.
The study population included patients that underwent a first liver transplant
between January 1, 2005 and October 1, 2014 (Figure 1). Exclusion criteria consisted of
the following: (1) Pediatric transplant (< 18 years); (2) Multi-organ transplant; (3)
UNOS Status 1 or acute liver failure;  (4)  ICU pre-transplant;  or (5)  Subjects with
missing data in any of the key variables of interest (variables with ≥ 5% missing
values were not  used in this  study).  Pediatric  and multi-organ transplants  were
excluded because the organ allocation systems for these patients are separate, and
represent a distinct set of indications and disease courses, than the general United
States liver transplant population. In addition, the risk of complications and graft loss
are higher in these groups. We excluded urgent (Status 1 or acute hepatic necrosis)
and ICU-admitted patients.  This  was done because these are often patients  who
rapidly  decline  due  to  an  inciting  event  (e.g.,  infection)  and  may,  therefore,  be
categorized as being of poor functional status due to the event as opposed to being
“frail”,  which  is  conceptualized  as  a  chronic  process  leading  to  depletion  of
physiologic reserve.
Data collection
Exposure variable:  The primary exposure of interest was provider assessment of
preoperative (“pre-transplant”) functional status using the KPS scale (Table 1). The
KPS defines functional status on an 11-point scale from 100% (normal, no complaints,
no evidence of disease) to 0% (dead) in 10% increments, with 3 corresponding tiers.
We used  the  3-tiered  version  of  the  scale  based  on  higher  inter-rater  reliability
scores[33].  We assigned labels  to the categories with respect  to level  of  functional
impairment/disability as follows: Subjects with minimal or no symptoms of disease
(80%-100%) were labeled “(A) None/Normal [function]”; subjects needing varying
levels  of  assistance  in  daily  activities  (50%-70%)  were  labeled  “(B)  Moderate
[impairment in function]”; and subjects who were disabled and/or hospitalization
indicated  and/or  moribund  (10%-40%)  were  labeled  “(C)  Severe  [functional
impairment/disability]”.
Study end points: The primary outcome of interest was 1-year all-cause mortality
(Social  Security Death Master File/Organ Procurement and Transplant Network
data). As mortality after transplantation is highest in the early postoperative period
and likely related to operative risks and complications that may become less relevant
for long-term outcomes, the importance of functional status may change with time
and  context[34].  Therefore,  we  also  examined  death  rates  during  the  1-month
postoperative period (day 0-30) as compared to residual risk during the remaining 11
months of the year (day 31-365). The secondary outcome of interest was 1-year graft
failure.
Lastly, among patients who did not experience either adverse outcome (death or
graft  failure),  we  describe  the  proportion  that  was  able  to  return  to  “Normal”
functional status during the first year post-transplant. Transplant centers must report
follow-up data  on  transplant  recipients  at  6-month  post-transplant,  1-year,  and
annually thereafter; follow-up records from day 0 to 395 (365 + 30 d) with functional
status data available (< 5% of recipients were missing follow-up functional status)
were analyzed (but counted once per patient).
Potential confounding variables: Potential confounders were identified from a priori
clinical  knowledge,  literature  review,  and  variables  included  in  the  SRTR risk-
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Figure 1
Figure 1  Study inclusion/exclusion criteria flow chart. Scientific Registry of Transplant Recipients.
adjustment models, available at srtr.org. Potential confounders included recipient
sociodemographic and medical/surgical history factors (i.e., information known at
least 2 weeks before transplant, e.g., primary liver diagnosis; Table 2), pre-transplant
illness severity markers (e.g., last-calculated laboratory MELD; Table 3), and all Donor
Risk Index factors (e.g., cause of death; Table 4)[34,35]. Every variable evaluated as a
potential  confounder was categorized and is described in Tables 2-4 (exceptions:
Baseline functional status, time on the waitlist, and MELD component labs are listed
for descriptive purposes only).
Statistical analysis
We explored bivariate relationships between the primary exposure (functional status)
and potential confounders of interest using contingency table analyses [chi-squared
tests for categorical variables, ANOVA for continuous variables, and Spearman’s rho
(rs)  for  ordered-variable  correlations,  using  expanded  KPS,  continuous  MELD].
Relationships between variables and post-transplant time were explored graphically.
One-year cumulative failure rates were estimated using the Kaplan Meier method.
To quantify the extent to which impaired functional status was associated with
increased risk of 1-year all-cause mortality and 1-year graft failure, we developed
separate Cox survival regression models for each outcome. We applied a manual
forward approach, sequentially adding conceptually meaningful groups of variables
to the model. With the exception of recipient age, sex, race/ethnicity, and MELD,
variables (and variable interactions) with p-values of > 0.05 were excluded from the
final model. Goodness-of-fit and proportionality of hazards were tested using the
omnibus Gronnesby and Borgan test and martingale residuals and confirmed non-
significant (no evidence of poor fit) for all models reported[36].
Results are reported as hazard ratios (HR) with 95% confidence interval (CI); P-
values ≤ 0.05 were considered statistically significant. All analyses were conducted
using Stata version 13 (StataCorp LP, College Station, TX, United States).
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Table 1  Karnofsky Performance Status scale and variable handling
Conditiona % Rating criteria
A (“None/Normal”) Able to carry on normal
activity and to work; no special care needed
100 Normal, no complaints; no evidence of disease
90 Able to carry on normal activity; minor signs or
symptoms of disease
80 Normal activity with effort; some signs or
symptoms of disease
B (“Moderate”) Unable to work; able to live at
home and care for most personal needs; varying
amount of assistance needed
70 Cares for self; unable to carry on normal activity
or to do active work
60 Requires occasional assistance, but is able to care
for most of his personal needs
50 Requires considerable assistance and frequent
medical care
C (“Severe”) Unable to care for self; requires
equivalent of institutional or hospital care;
disease may be progressing rapidly
40 Disabled; requires special care and assistance
30 Severely disabled; hospital admission is indicated
although death not imminent
20 Very sick; hospital admission necessary; active
supportive treatment necessary
10 Moribund; fatal processes progressing rapidly
0 Dead
aAuthor-assigned variable labels in parentheses.
RESULTS
Sample characteristics
The final study sample included 38278 liver transplant recipients (Figure 1).  The
median [interquartile range (IQR)] age was 56 (51-61) years and MELD was 18 (12-25).
Women  represented  31%  of  the  sample  and  the  largest  ethnic  minority  was
Hispanic/Latino  (12.7%).  Median  follow-up  time  was  3.3  (1.5-6.0)  years  after
transplant.
At pre-transplant assessment, approximately 70% of the sample had some degree of
functional impairment or disability. Approximately one-quarter (23.7%) had “Severe”
functional  impairment/disability  (≤  40%  function),  45.8%  were  “Moderately”
impaired, and the remaining 30.5% had no functional impairments (≥ 80% function).
The median (IQR) pre-transplant functional performance status score was 60% (50%-
80%) and the mean (standard deviation) was 61% (21%).
Baseline characteristics and changes over waitlist course
Table 2 describes baseline characteristics of the sample by category of pre-transplant
functional status. Subjects who were of worse functional status pre-transplant were
more likely to be female, of Hispanic/Latino race/ethnicity, and/or have Medicaid
insurance.  Primary  diagnosis  of  hepatic  malignancy  was  associated  with  better
physical function. Baseline and pre-transplant functional status were moderately
correlated (rs = 0.42, P < 0.001). Sixty-percent of recipients maintained the same level
of  function over  their  waitlist  course  while  30% declined from a higher  level  of
function at baseline.
Table 3 describes recipient clinical characteristics pre-transplant by category of pre-
transplant functional status. Significant weight loss (≥ 5% of baseline weight) over the
waitlist  period  was  more  common  among  transplant  recipients  who  were
impaired/disabled pre-transplant, and the weight loss occurred more rapidly. Poor
functional status was moderately correlated with worse (higher) MELD scores (rs = -
0.49;  P  <  0.001).  However,  only  64%  of  subjects  with  MELD  scores  ≥  30  were
“Severely” impaired/disabled, and less than half (44%) of patients with MELD scores
< 15 were of “Normal” functional status. Cirrhosis severity according to Child-Pugh
class  was  associated with  severity  of  functional  status.  Around 10% of  severely
impaired subjects  were on dialysis  pre-transplant,  compared to < 1% of  Normal
functional status subjects.
Table 4 describes donor characteristics by categories of pre-transplant functional
status.  Donor  characteristics  were  mostly  comparable  across  functional  status
categories.  Only  8.3%  of  living  donor  liver  transplant  recipients  was  Severely
impaired/disabled (n = 729). Functionally impaired patients were slightly less likely
to receive higher risk organs (e.g.,  donor ≥ 70 years,  nationally allocated or with
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Table 2  Baseline characteristicsa by pre-transplant functional status, Scientific Registry of Transplant Recipients 2005-2014 (n = 38278)
Characteristicb
Functional impairment/disability
A: None (n = 11674) B: Moderate (n = 17530) C: Severe (n = 9074)
Sociodemographics
Age in years
18-44 11.6 10.3 12.7
45-54 28.9 30.2 32.1
55-64 44.9 45.3 43.2
≥ 65 14.5 14.3 12.0
Women 26.8 32.1 33.4
Race/ethnicity
White 73.1 74.3 70.4
Hispanic/Latino 10.6 12.5 15.9
Black 8.9 8.4 9.1
Health insurance
Private 68.1 55.3 54.2
Medicare 18.5 26.5 24.6
Medicaid 8.8 14.0 17.0
Medical/Surgical History
Functional impairment at registration
None 74.6 33.4 22.4
Moderate 19.9 57.0 35.4
Severe 2.5 6.6 37.0
Primary cause of liver disease
Non-Cholestatic 56.2 64.7 75.8
Cholestatic 9.5 8.1 7.8
Malignancy 30.1 23.0 12.5
Hepatitis C 44.4 45.5 42.1
Diabetesc 23.2 25.8 25.3
Previous Abdominal Surgery 46.2 51.6 50.3
aCharacteristics known at least 2 weeks prior to transplant;
bColumn percentage;
cDiabetes types 1, 2, or unspecified. All distributions varied significantly across categories of functional status (P < 0.001).
prolonged cold ischemia time).
All-cause mortality
Death  within  one  year  was  observed  in  3595  (9.4%)  transplant  recipients.  The
mortality rate was directly related to functional status. Among patients that were
severely impaired/disabled, 12.8% died compared with 9.3% of those with moderate
functional limitations and 6.9% of those with normal functional status at the time of
transplant.
Table 5 describes the results of unadjusted and adjusted Cox regression models for
1-year  mortality.  Subjects  with  severe  or  moderate  functional  impairment  pre-
transplant  were  at  significantly  increased  risk  of  dying  within  one  year  post-
transplant.  After  multivariable  adjustment,  severely  and  moderately  impaired
patients had 1-year mortality rates that were 1.73 (CI: 1.56-1.91) and 1.32 (CI: 1.21-1.44)
times  greater  than  the  hazard  for  subjects  without  any  functional  impairment,
respectively.
Mortality risks were greatest in the immediate postoperative period (day 0-30)
when 881 (2.3%) deaths were observed in a single month. The adjusted 30-d mortality
risk for Severely impaired/disabled patients was more than double (HR: 2.10; CI:
1.71-2.59)  that  of  patients  of  “Normal”  functional  status,  after  adjusting  for  all
variables controlled for in the full 1-year survival model (Table 5). Approximately
three-quarters (n = 2714) of all one-year deaths occurred during the remaining 11 mo
of the postoperative year (day 31-365); HRs were comparable to estimates for overall
one-year mortality (< 10% relative difference).
WJT https://www.wjgnet.com November 20, 2019 Volume 9 Issue 7
Dolgin NH et al. Functional status and 1-year outcomes
150




A: None (n = 11674) B: Moderate (n = 17530) C: Severe (n = 9074)
Waitlist time, mo 4.0 (1.3-10.2) 3.7 (1.1-10.3) 2.1 (0.4-8.4)
Weight loss ≥ 5%b 19.7 24.2 27.0
BMI, kg/m2
Underweight (< 18.5) 1.6 1.6 2.4
Normal (18.5-25) 28.3 27.5 27.1
Overweight (25-30) 37.0 36.0 34.0
Obese (≥ 30) 33.2 35.0 36.5
MELD
< 15 49.9 34.9 14.3
15-29 45.9 56.5 45.9
≥ 30 4.2 8.6 39.8
Total bilirubin 2.3 (1.2-4.4) 3.0 (1.6-6.1) 6.6 (2.9-17.2)
International normalized ratio 1.4 (1.2-1.7) 1.5 (1.3-1.9) 2.0 (1.5-2.6)
Serum creatinine 0.9 (0.7-1.2) 1.0 (0.8-1.3) 1.4 (0.9-2.3)
Serum sodium 137 (134-140) 136 (133-139) 135 (132-139)
Child Pugh score
A (Good) 23.8 11.8 4.1
B (Fair) 38.7 33.8 18.5
C (Poor) 37.5 54.4 77.4
Ascitesc
None 36.9 23.0 14.0
Mild/Moderate 48.4 52.4 43.5
Severe 14.8 24.6 42.6
Encephalopathyd
None 52.7 36.6 26.0
Grade 1-2 44.4 57.5 61.4
Grade 3-4 2.9 5.9 12.6
Albumin
> 3.5 26.7 19.3 22.8
2.8-3.5 41.7 41.2 39.0
< 2.8 31.6 39.6 38.2
Dialysise 0.9 1.6 10.9
Portal Vein Thrombosis 6.5 9.7 12.4
aColumn percentage or median (interquartile range);
bRelative to weight at time of waitlist registration;
cMild/Moderate ascites: Diuretic-responsive; Severe ascites: Diuretic-refractory;
dEncephalopathy grade 1-2 (or precipitant-induced); Grade 3-4 (or chronic);
eDialyzed at least twice in prior week. All distributions varied significantly across categories of functional status (P < 0.001). BMI: Body mass index; MELD:
Model for End-Stage Liver Disease.
Graft failure
Graft  failure  was  observed  in  2214  of  the  study  population  within  one  year  of
transplant. The estimated failure rate on day 365 was 6.2% (cumulative failure or
death  rate  on  day  365:  12.7%).  Approximately  half  (53.8%)  received  a  second
transplant within the first post-transplant year, of which 75.9% (n = 905) survived the
year; 98.6% (n = 1008) of those who did not undergo retransplantation within the first
postoperative year did not survive to 1-year post-transplant.
Table 6 describes the results of unadjusted and adjusted Cox regression models for
1-year graft failure. Subjects with severe and moderate impairment/disability had
multivariable-adjusted 1-year graft failure rates that were 1.16 (CI: 1.02-1.31) and 1.13
(CI: 1.02-1.24) times higher than patients with normal function, respectively.
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A: None (n = 11674) B: Moderate (n = 17530) C: Severe (n =9074)
Transplant type: Living donor 5.5 5.0 2.3 < 0.001
Donor Risk Indexb 1.6 (1.3-1.9) 1.6 (1.3-1.9) 1.5 (1.2-1.9) < 0.001
Age in years
18-39 37.3 37.1 39.9
40-49 19.7 19.7 19.7
50-59 19.8 20.4 20.7
60-69 11.7 12.7 10.8
≥ 70 5.5 4.9 3.9 < 0.001
Women 40.5 41.4 40.9 0.35
Race/ethnicity
White 68.2 68.1 65.6
Black 17.2 17.9 17.5
Other 14.6 14.0 16.9 < 0.001
BMI, kg/m2
Underweight (< 18.5) 2.9 2.9 2.6
Normal (18.5-25) 36.5 35.9 36.2
Overweight (25-30) 33.5 34.2 33.4
Obese (≥ 30) 27.1 27.0 27.9 0.43
Cause of death
Trauma 34.3 34.1 34.1
Anoxia 21.5 22.5 24
Cardiovascular accident 41.4 40.9 39.4 < 0.01
Donation after cardiac death 12.6 13.2 12.1 0.04
Split/Partial liver 1.5 1.4 1.3 0.38
Allocation type
Regional 17.8 19.9 23.3
National 6.6 5.0 3.8 < 0.001
Cold ischemia time ≥ 8 h 30.9 28.9 27.9 < 0.001
aColumn percentage or median (interquartile range);
bDonor risk index as described by Feng et al[35], 2006. BMI: Body mass index.
Functional status post-liver transplant
Among the 33764 (88.2%) transplant recipients who experienced neither outcome
(death  or  graft  failure  within  a  year),  95% (n  =  32004)  had  at  least  1  follow-up
functional status assessment within a year.  The majority (86.3%) recovered from
transplant  and  reached  “Normal”  functional  status  within  1  year.  Of  the  7258
recipients in this subsample that were severely impaired/disabled pre-transplant,
81% (n = 5861) recovered full physical function (“Normal” functional status) within 1
year of transplant.
DISCUSSION
Almost 1 in 4 patients included in this national study of 38278 United States adults
that underwent non-urgent liver transplantation between 2005 and 2014 had severe
functional impairment/disability at the time of transplant. This group of patients was
found to have a markedly increased hazard of dying and/or having graft failure at 1
year  compared to  Normal  functional  status  patients.  This  increased hazard was
observed  in  both  unadjusted  and  multivariable-adjusted  regression  analyses
controlling for a variety of potentially confounding factors of prognostic importance.
Approximately 86% of recipients who did not experience 1-year death or graft failure
(and had follow-up data available) recovered from transplant and reached “Normal”
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Table 5  Association between pre-transplant functional status and 1-year (all-cause) post-transplant mortality, Scientific Registry of
Transplant Recipients 2005–2014 (n = 38278a)
Functional impairment/disability
Hazard Ratio (95%CI)
1-Yr Day 0-30c Day 31-365d
Unadjusted Adjustedb Unadjusted Adjustedb Unadjusted Adjustedb
Severe 1.94 (1.77-2.13) 1.73 (1.56-1.91) 2.40 (1.99-2.89) 2.10 (1.71-2.59) 1.82 (1.64-2.02) 1.62 (1.45-1.82)
Moderate 1.38 (1.27-1.51) 1.32 (1.21-1.44) 1.60 (1.34-1.92) 1.53 (1.27-1.83) 1.33 (1.20-1.46) 1.26 (1.15-1.40)
None Referent Referent Referent
aAdjusted model n = 380762 [missing albumin (n = 1) or donor body mass index (n = 200)];
bAdjusted for recipient age, sex, race, insurance, body mass index (BMI), diabetes, previous abdominal surgery, liver disease, MELD, albumin, portal vein
thrombosis, dialysis; donor age, race, BMI, donor type (living or deceased) and cause of death, donation after cardiac death, allocation type, cold ischemia
time ≥ 8 hours; interactions: recipient BMI and diabetes, recipient hepatitis C and portal vein thrombosis, recipient hepatitis C and donor age;
cPostoperative day 0-30: n = 38,278; 881 deaths;
dPostoperative day 31-365: n = 37352; 2714 deaths. BMI: Body mass index; CI: Confidence interval; MELD: Model for End-Stage Liver Disease.
functional status within 1-year.
We present data from the first national study illustrating the role of pre-transplant
functional status as a predictor of one-year survival among liver transplant recipients.
Our results are in agreement with the findings from earlier studies that evaluated
Poor functional status as a predictor of adverse transplant outcomes[11,28-30]. Two such
studies,  each  with  approximately  4000  United  Kingdom  recipients  of  a  liver
transplant, reported a near 2-fold increased risk of post-transplant mortality at 90 d
for the worst functioning group relative to the highest functioning group[11,30]. Studies
have  also  shown that  objective  measures  of  physical  function,  such  as  walking
distance  or  speed and grip  strength,  are  also  strong  predictors  of  adverse  liver
transplant  outcomes  regardless  of  recipient  age,  size,  or  cause/severity  of  liver
disease[29].
Implications
Insight into a transplant patient’s  global health status guides day-to-day clinical
management, as well as transplant decisions, particularly in the face of contradictory
laboratory or otherwise objective measures of pathological disease progression (e.g.,
MELD score). Capturing such insight through the use of a quantitative physical health
scale may help transplant teams to strategize and communicate complex medical and
surgical management decisions with patients, families, and the many other members
of  multidisciplinary  transplant  teams  that  provide  longitudinal  care  for  liver
transplant patients.
Knowledge of a patient’s functional status before transplant may practically assist
transplant  teams  to  anticipate,  communicate,  and  coordinate  resources  for
postoperative critical care, rehabilitation after discharge, and potentially longer-term
occupational therapy to help patients recover physical health and quality of life[37].
Many well-established risk factors for adverse outcomes among patients undergoing
liver transplant may be unpredictable or sudden (spontaneous bacterial peritonitis),
unavoidable (older age), and/or untreatable (portal vein thrombosis). Furthermore,
many of the strongest predictors of adverse outcomes are present in a relatively small
percentage of the liver transplant population. Many risk factors are unknown until
very  close  to  transplant  time  (e.g.,  life  support,  cold  ischemia  time),  whereas
functional impairment can present very early and progress insidiously in end-stage
liver disease patients over the course of waiting for an organ. All patients can also be
assigned a value for functional status at baseline, which can be used as a reference
point  to  assess  change over  time.  While  this  scale  is  an all-encompassing global
physical function measure and a patient can fall anywhere on the continuous scale,
many risk factors considered in transplant decisions are individual dichotomous
variables, which are usually assessed in combination with other risk factors that can
take time to accumulate. Thus, as functional status is a harbinger of adverse outcomes
and may present early, it may be a useful clinical tracking tool that can be used for
strategic care management.
Promising interventional studies have also shown that “prehabilitation”, physical
therapy  (e.g.,  strength  training)  and  nutritional  support,  designed  to  improve
functional status (or slow decline) in anticipation of a physiologic stressor such as
surgery[38,39],  is  effective at improving postoperative recovery and outcomes after
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Table 6  Association between pre-transplant functional status and 1-year graft failure, Scientific
Registry of Transplant Recipients 2005-2014 (n = 38278)
Functional impairment/disability Events, na
Hazard Ratio (95%CI)
Unadjusted Adjustedb
Severe 527 1.10 (0.98-1.23) 1.16 (1.02-1.31)
Moderate 1051 1.12 (1.01-1.23) 1.13 (1.02-1.24)
None 636 Referent Referent
aNumber of graft failures within 1 year of liver transplantation;
bAdjusted for recipient age, sex, race, body mass index (BMI), primary diagnosis of liver disease, MELD,
portal vein thrombosis; donor age, race, BMI, donor type (living or deceased) and cause of death, donation
after cardiac death, cold ischemia time ≥ 8 h; interactions: recipient hepatitis C and portal vein thrombosis,
recipient hepatitis C and donor age. BMI: Body mass index; CI: Confidence interval; MELD: Model for End-
Stage Liver Disease.
major  abdominal  surgery[40-44].  Although  none  of  these  studies  focused  on  liver
transplant patients, several included cohorts that similarly have a high likelihood of
becoming  frail  due  malnutrition,  inflammation,  and  sarcopenia  (e.g.,  cancer
patients[41,42] and older populations[43,44]). Prehabilitation has the potential for providing
clinicians with a way to not only recognize, but also slow or prevent decline to the
point of “Severe” impairment/disability. However, more research on prehabilitation
specific to a liver disease population is warranted. Frailty due to liver failure may not
respond to the same interventions that have successfully slowed progression of frailty
due to aging as there may be fundamental differences in etiology and pathogenesis
between these populations that may limit their effectiveness[45].
Strengths and limitations
Strengths of this study include its use of the SRTR with complete capture of every
solid organ transplant  in the United States  since 1987,  including waitlist,  donor,
follow-up, and external data file linkages (e.g.,  Social Security Death Master File).
Mandated  reporting  of  KPS  providing  more  than  a  decade  of  nationally
representative data on functional status is also a major strength of our investigation.
This study is limited by reliance on the less-than-ideal KPS scale as it is the only
available measure of functional status in the SRTR. The KPS uses multiple domains in
the  assessment  of  function  and  concern  may  arise  that  it  is  less  objective  or
standardized than direct measures of frailty such as grip strength or walking distance.
However, the KPS has been extensively validated across a wide range of diseases over
the last 60 years, and the simplest 3-tiered scale version used in this analysis has
shown excellent inter-rater reliability regardless of provider type or setting[33]. The
KPS has in fact been validated in transplant populations specifically, compared with
the Short Form survey and other physical function scales for liver disease patients[46],
and extensively validated in end-stage renal disease populations[14,19].
Several different measures of physical function and composite frailty scores have
been used in the literature and were effective predictors of waitlist and transplant
outcomes. However, such direct measures of frailty would demand more resources
(time, training, materials) from transplant centers than the KPS alone. Furthermore,
their advantages over the use of the KPS should be evaluated in terms of predictive
value (area under the curve) before major investment in resource-intensive measures
that may already capture similar predictive information.
In summary, we have demonstrated that there is substantial value in using a simple
3-point functional status scale for predicting one-year liver transplant outcomes. We
highlight areas where future research may further the validity, and ultimately, the
clinical utility of the Karnofsky Functional Performance scale in a liver transplant
population. It is important to continue to develop objective measures for describing
global health status and illness severity to help in the allocation of organs and waitlist
management, patient health improvement, and accurate adjustment for transplant
center case-mix for transplant reimbursement.
ARTICLE HIGHLIGHTS
Research background
Frailty is increasingly recognized as an important predictor of outcomes after major surgical
procedures including liver transplantation. The Karnofsky Performance Status (KPS) scale has
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been widely validated for clinical practice for over 60 years.
Research motivation
To investigate the impact of frailty on liver transplant outcomes.
Research objectives
We wanted to determine the extent to which poor pre-transplant functional status, assessed
using the KPS scale, is associated with increased risk of mortality and/or graft failure at 1-year
post-transplantation. This would give clinicians some objective assessment and help on the
decision to allocate livers for high-risk recipients.
Research methods
This study included 38278 United States adults who underwent first, non-urgent, liver-only
transplantation from 2005 to 2014 (Scientific Registry of Transplant Recipients).  Functional
impairment/disability was categorized as severe (10%-40% of optimal function), moderate (50%-
70%), or none/normal (80%-100%). Analyses were conducted using multivariable-adjusted Cox
survival regression models. We explored bivariate relationships between the primary exposure
(functional status) and potential confounders of interest using contingency table analyses [chi-
squared tests for categorical variables, ANOVA for continuous variables, and Spearman's rho (rs)
for ordered-variable correlations, using expanded KPS, continuous Model for End-Stage for
Liver Disease (MELD)]. Relationships between variables and post-transplant time were explored
graphically. One-year cumulative failure rates were estimated using the Kaplan Meier method.
Research results
The  median  age  was  56  years,  31%  were  women,  median  pre-transplant  MELD  was  18.
Functional impairment was present in 70%; one-quarter of the sample was severely disabled.
After controlling for key recipient and donor factors, moderately and severely disabled patients
had a 1-year mortality rate of 1.32 [confidence interval (CI): 1.21-1.44] and 1.73 (95%CI: 1.56-1.91)
compared to patients with no impairment, respectively. Subjects with moderate and severe
disability also had a multivariable-adjusted 1-year graft failure rate of 1.13 (CI: 1.02-1.24) and
1.16 (CI: 1.02-1.31), respectively.
Research conclusions
Pre-transplant functional status is a useful prognostic indicator for 1-year post-transplant patient
and graft survival. It is important to continue to develop objective measures for describing global
health status and illness severity to help in the allocation of organs and waitlist management,
patient  health  improvement,  and  accurate  adjustment  for  transplant  center  case-mix  for
transplant reimbursement. We present data from the first national study illustrating the role of
pre-transplant functional status as a predictor of  one-year survival  among liver transplant
recipients. Our results are in agreement with the findings from earlier studies that evaluated
Poor functional status as a predictor of adverse transplant outcomes. We have not proposed any
theory. The index of frailty - The KPS scale - can be used as a predictor of 1-year post-transplant
outcomes (patient and graft survival) in a national United States liver transplant population.
Poor functional status predicts 1-year post-liver transplant outcomes. No new methods were
proposed. We used very well-established methods of outcome research. It will help to determine
objective measures for describing frailty and overall clinical status to help in the allocation of
organs and waitlist management, patient health improvement, transplant reimbursement, and
policy changes.
Research perspectives
That patients’ pre-transplant frailty plays a critical role in transplant outcomes and the transplant
community need to study it with more detail. To perform prospective and randomized studies
associating frailty index with other biomarkers and correlate them with transplant outcomes.
Associating frailty indexes with other biomarkers and correlate them with transplant outcomes.
To measure the impact of interventions to improve frailty pre-transplant and correlate it with
outcomes.
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